Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Prostatic Neoplasms 2 Neoplasms 2 Weight Loss 1 Polyps 1 Osteoporosis 1 Myocardial Ischemia 1 Myocardial Infarction 1 Metabolic Syndrome 1 Lung Neoplasms 1 Heart Diseases 1 Diabetes Mellitus 1 Depression 1 Coronary Disease 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Cardiovascular Diseases 1 Carcinoma, Renal Cell 1 Bone Diseases 1 Body Weight Changes 1 Angina, Unstable 1 Adenoma 1

Interventions

Exercise 10 Diet 6 Caloric Restriction 5 Nutrition Assessment 4 Metformin 4 Octreotide 3 Megestrol Acetate 3 Cognitive Behavioral Therapy 3 anamorelin 2 Standard of Care 2 Olanzapine 2 Mirtazapine 2 Melatonin 2 Liraglutide 2 Eicosapentaenoic Acid 2 Diet, Carbohydrate-Restricted 2 Diet Therapy 2 sibutramine 1 remune 1 olanzapine-fluoxetine combination 1 lime 1 irinotecan sucrosofate 1 bermekimab 1 Weight Reduction Programs 1 Urine Specimen Collection 1 Tirzepatide 1 TOPS 1 Surveys and Questionnaires 1 Sugars 1 Sampling Studies 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Weight Loss × Diet, Fat-Restricted × Clear all

NCT01559194 2014-04-14

LEAF

Ohio State University Comprehensive Cancer Center

Phase 3 Completed

Breast Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡